Cryomass Technologies Inc. Stock Analysis CRYM

CryoMass Technologies, Inc. engages in the operation of medical marijuana dispensaries and related businesses. The company is headquartered in Denver, Colorado. The company went IPO on 2013-11-26. The Company’s patented technology harnesses liquid nitrogen to reduce biomass and then efficiently isolate, collect, and preserve delicate resin glands (trichomes) containing prized compounds like cannabinoids and terpenes. Building on this technology, CryoMass has engineered its Trichome Separation unit (CryoSift Separator), optimized via patented cryogenic processes to rapidly capture intact, high-value cannabis and hemp trichomes (CryoSift). For cultivators, reducing biomass into CryoSift slashes volume up to 80%, dramatically lowering storage, handling, and transportation costs. CryoMass anticipates its efficiencies will catalyze industry-wide shifts in cannabis and hemp post- harvest methods. Its business portfolio includes the accounts of Cryomass LLC, Cryomass California LLC and 1304740 BC ULC doing business as Cryomass Canada.